Peter N. Laivins
Direktor/Vorstandsmitglied bei GENEXINE, INC.
Aktive Positionen von Peter N. Laivins
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENEXINE, INC. | Direktor/Vorstandsmitglied | - | - |
| Independent Dir/Board Member | - | - |
Karriereverlauf von Peter N. Laivins
Ehemalige bekannte Positionen von Peter N. Laivins
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.10.2011 | 01.04.2017 |
Elan Biopharmaceuticals, Inc.
 Elan Biopharmaceuticals, Inc. Medical DistributorsDistribution Services Elan Biopharmaceuticals, Inc. distributes drugs and pharmaceuticals. It currently distributes three concentrated morphine sulfate oral solutions which include RoxanolT CII, Roxanol-TT CII and Roxanol 100T CII. Elan Biopharmaceuticals is located in San Diego, CA. | Vertrieb & Marketing | - | 01.01.2010 |
Ausbildung von Peter N. Laivins
| McGill University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 3 |
| Kanada | 2 |
| Südkorea | 2 |
Operativ
| Sales & Marketing | 1 |
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 3 |
| Distribution Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENEXINE, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Elan Biopharmaceuticals, Inc.
Elan Biopharmaceuticals, Inc. Medical DistributorsDistribution Services Elan Biopharmaceuticals, Inc. distributes drugs and pharmaceuticals. It currently distributes three concentrated morphine sulfate oral solutions which include RoxanolT CII, Roxanol-TT CII and Roxanol 100T CII. Elan Biopharmaceuticals is located in San Diego, CA. | Distribution Services |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Peter N. Laivins
- Erfahrung
